Format

Send to

Choose Destination
Biomed Pharmacother. 2015 Aug;74:145-7. doi: 10.1016/j.biopha.2015.08.002. Epub 2015 Aug 13.

Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.

Author information

1
Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
2
Department of Cardiology, The First Clinical Hospital of Harbin Medical University, Harbin 150086, China.
3
Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China. Electronic address: learnharder@126.com.

Abstract

Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes and remains a major cause of preventable blindness among adults at working age. DR involves an abnormal pathology of major retinal cells, including retinal pigment epithelium, microaneurysms, inter-retinal oedema, haemorrhage, exudates (hard exudates) and intraocular neovascularization. Hyperglycemia is the driving force for the development of diabetic retinopathy. The exact cause of diabetic nephropathy is unknown, but various postulated mechanisms are: hyperglycemia, advanced glycosylation products, activation of cytokines. In this review article, we have discussed a number of diabetes-induced metabolites such as glucose, advanced glycation end products, protein kinase C and oxidative stress and other related factors that are implicated in the pathophysiology of the DR. An understanding of the biochemical and molecular changes especially early in the DR may lead to new and effective therapies towards prevention and amelioration of DR.

KEYWORDS:

Advanced glycation end products; Diabetic retinopathy; Hyperglycemia; Oxidative stress; Protein kinase C

PMID:
26349976
DOI:
10.1016/j.biopha.2015.08.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center